Trade GlaxoSmithKline plc (Extended hours) - GSK CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.34 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023457% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001235% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 38.46 |
| Open | 38.46 |
| 1-Year Change | -10.1% |
| Day's Range | 37.78 - 38.46 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 26, 2025 | 38.10 | -0.35 | -0.91% | 38.45 | 38.51 | 37.69 |
| Mar 25, 2025 | 38.50 | 0.13 | 0.34% | 38.37 | 39.31 | 38.03 |
| Mar 24, 2025 | 38.50 | -0.86 | -2.18% | 39.36 | 39.49 | 38.36 |
| Mar 21, 2025 | 38.95 | -0.42 | -1.07% | 39.37 | 39.87 | 38.95 |
| Mar 20, 2025 | 39.30 | 0.44 | 1.13% | 38.86 | 39.71 | 38.66 |
| Mar 19, 2025 | 39.50 | -0.03 | -0.08% | 39.53 | 39.73 | 38.91 |
| Mar 18, 2025 | 40.02 | 0.18 | 0.45% | 39.84 | 40.33 | 39.09 |
| Mar 17, 2025 | 40.14 | 0.78 | 1.98% | 39.36 | 40.41 | 39.34 |
| Mar 14, 2025 | 39.41 | 0.66 | 1.70% | 38.75 | 39.55 | 38.75 |
| Mar 13, 2025 | 38.95 | 0.20 | 0.52% | 38.75 | 39.33 | 38.59 |
| Mar 12, 2025 | 38.75 | -0.88 | -2.22% | 39.63 | 39.65 | 38.73 |
| Mar 11, 2025 | 39.45 | -0.19 | -0.48% | 39.64 | 40.63 | 39.28 |
| Mar 10, 2025 | 40.03 | 0.80 | 2.04% | 39.23 | 40.75 | 39.23 |
| Mar 7, 2025 | 39.98 | 0.97 | 2.49% | 39.01 | 40.53 | 38.99 |
| Mar 6, 2025 | 38.91 | 0.24 | 0.62% | 38.67 | 39.36 | 38.26 |
| Mar 5, 2025 | 38.72 | 0.48 | 1.26% | 38.24 | 38.80 | 38.22 |
| Mar 4, 2025 | 38.40 | 0.55 | 1.45% | 37.85 | 39.13 | 37.75 |
| Mar 3, 2025 | 37.85 | 0.41 | 1.10% | 37.44 | 38.35 | 37.44 |
| Feb 28, 2025 | 36.97 | -0.20 | -0.54% | 37.17 | 37.63 | 36.97 |
| Feb 27, 2025 | 37.17 | -0.02 | -0.05% | 37.19 | 37.44 | 36.92 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
GlaxoSmithKline Company profile
About GlaxoSmithKline plc (ADR)
GlaxoSmithKline PLC is a global healthcare company. The Company researches and develops a range of products in three primary areas: Pharmaceuticals, Vaccines and Consumer Healthcare. Its product formulations include tablets, creams/ointments, inhalers, injections, liquids and sterile products. Its Pharmaceuticals business has a portfolio of established medicines in respiratory, human immunodeficiency virus (HIV), immuno-inflammation and oncology. Its Vaccines business has a portfolio of vaccines to help protect people from a range of diseases throughout their lives. Its vaccines tackle diseases, including pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough and influenza. Its Consumer Healthcare business combines science and consumer insights to create everyday healthcare brands that consumers trust, and experts recommend for oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals and supplements.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, GlaxoSmithKline plc (ADR) revenues increased less than 1% to £34.11B. Net income decreased 24% to £4.39B. Revenues reflect Pharmaceuticals segment increase of 4% to £17.73B, US segment increase of 4% to £15.09B, also reflect Consumer Healthcare segment decrease of 4% to £9.61B, Vaccines segment decrease of 3% to £6.78B, Unallocated segment decrease from £28M to £0K.
Equity composition
Ordinary Shs. 25p Par, 05/11, 10B auth., 5,657,488,184 issd., less 494,074,284 Treas. shs. @ Cost. Insiders own 0.02%. PO: NA. 11/91, 9/89, & 2/86,2-for-1 stock splits. 2/00, Company formed through merger with SmithKline Beecham plc @ 1 ADR-for-1.138 ADS of GSK and Glaxo Wellcome plc @ 1.
| Industry: | Pharmaceuticals (NEC) |
980 Great West Road
BRENTFORD
MIDDLESEX TW8 9GS
GB
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com